Company news: MGC Pharma; AusCann; Creso Pharma; Canopy Growth by Martin Lane September 16, 2021September 16, 2021 MGC Pharma MGC Pharma’s CannEpil+ epilepsy treatment has been approved for import by the UK’s Medicines […]
Althea completes A$10.64m capital raise and sets sights on ‘material growth’ by Steve Jones August 25, 2021August 26, 2021
Canopy Growth buys Supreme Cannabis, eyes further US expansion by Martin Lane April 9, 2021April 9, 2021
Highlands Investments launches Africa’s first contract cultivation offering by Martin Lane January 21, 2021January 21, 2021
Creso Pharma snags Canopy Growth founder Bruce Linton as strategic advisor by Martin Lane October 7, 2020October 8, 2020
TGA audit finds some medical cannabis products do not match potency claims by Martin Lane September 22, 2020September 23, 2020
Emerald Clinics signs UK deal with world’s largest cannabis company by Martin Lane August 11, 2020August 11, 2020
Germany shows Australia the way as cost remains key barrier for patients by Steve Jones July 2, 2020August 5, 2020
